Anbio Biotechnology (NNNN) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $3.30, -7.56% vs the prior close of $3.57.
- Volume 69.70K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NNNN slides 7.6% to $3.30, a 52-week low, 4 down days in a row. Closed at $3.30, -7.56% vs the prior close of $3.57. Day range $3.09–$3.70, opened at $3.53.
NNNN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — NNNN slides 7.6% to $3.30, a 52-week low, 4 down days in a row
- Closed at $3.30, -7.56% vs the prior close of $3.57. Day range $3.09–$3.70, opened at $3.53.
- Volume was 69.70K shares, 0.4x its 50-day average of 175.36K — lighter than usual.
- Price is -50.8% vs its 50-day average ($6.71) and -82.6% vs its 200-day average ($19.00).
- 52-week range $3.09–$44.73; today's close sits at 1% of that range, 92.6% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — NNNN slides 16.2% to $3.57, a 52-week low, 3 down days in a row
- Closed at $3.57, -16.20% vs the prior close of $4.26. Day range $3.52–$4.26, opened at $4.26.
- Volume was 30.60K shares, 0.2x its 50-day average of 176.11K — lighter than usual.
- Price is -47.8% vs its 50-day average ($6.84) and -81.4% vs its 200-day average ($19.15).
- 52-week range $3.52–$44.73; today's close sits at 0% of that range, 92.0% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — NNNN slides 3.4% to $4.26, a 52-week low
- Closed at $4.26, -3.40% vs the prior close of $4.41. Day range $3.88–$4.43, opened at $4.40.
- Volume was 46.00K shares, 0.3x its 50-day average of 177.62K — lighter than usual.
- Price is -38.9% vs its 50-day average ($6.98) and -77.9% vs its 200-day average ($19.30).
- 52-week range $3.88–$44.73; today's close sits at 1% of that range, 90.5% below the 52-week high.
Oct 12, 2026 — NNNN slides 5.4% to $4.41, a 52-week low
- Closed at $4.41, -5.36% vs the prior close of $4.66. Day range $4.41–$4.68, opened at $4.61.
- Volume was 24.90K shares, 0.1x its 50-day average of 177.78K — lighter than usual.
- Price is -37.9% vs its 50-day average ($7.10) and -77.3% vs its 200-day average ($19.45).
- 52-week range $4.16–$44.73; today's close sits at 1% of that range, 90.1% below the 52-week high.
Oct 9, 2026 — NNNN rises 0.9% to $4.66
- Closed at $4.66, +0.87% vs the prior close of $4.62. Day range $4.16–$5.16, opened at $4.63.
- Volume was 69.80K shares, 0.4x its 50-day average of 178.79K — lighter than usual.
- Price is -35.4% vs its 50-day average ($7.21) and -76.2% vs its 200-day average ($19.60).
- 52-week range $4.16–$44.73; today's close sits at 1% of that range, 89.6% below the 52-week high.
Oct 8, 2026 — NNNN slides 5.7% to $4.62, a 52-week low
- Closed at $4.62, -5.71% vs the prior close of $4.90. Day range $4.55–$4.81, opened at $4.81.
- Volume was 34.70K shares, 0.2x its 50-day average of 179.16K — lighter than usual.
- Price is -37.0% vs its 50-day average ($7.34) and -76.6% vs its 200-day average ($19.75).
- 52-week range $4.55–$44.73; today's close sits at 0% of that range, 89.7% below the 52-week high.
Oct 7, 2026 — NNNN ends flat (+0.0%) to $4.90
- Closed at $4.90, +0.00% vs the prior close of $4.90. Day range $4.72–$4.99, opened at $4.76.
- Volume was 36.70K shares, 0.2x its 50-day average of 179.04K — lighter than usual.
- Price is -34.4% vs its 50-day average ($7.48) and -75.4% vs its 200-day average ($19.89).
- 52-week range $4.66–$44.73; today's close sits at 1% of that range, 89.0% below the 52-week high.
Oct 6, 2026 — NNNN rises 1.4% to $4.90
- Closed at $4.90, +1.45% vs the prior close of $4.83. Day range $4.69–$5.15, opened at $4.89.
- Volume was 52.80K shares, 0.3x its 50-day average of 178.27K — lighter than usual.
- Price is -35.4% vs its 50-day average ($7.58) and -75.5% vs its 200-day average ($20.01).
- 52-week range $4.66–$44.73; today's close sits at 1% of that range, 89.0% below the 52-week high.
Oct 5, 2026 — NNNN slides 13.0% to $4.83, a 52-week low, 3 down days in a row
- Closed at $4.83, -12.97% vs the prior close of $5.55. Day range $4.66–$5.60, opened at $5.60.
- Volume was 107.40K shares, 0.6x its 50-day average of 176.46K.
- Price is -37.2% vs its 50-day average ($7.69) and -76.0% vs its 200-day average ($20.15).
- 52-week range $4.66–$51.33; today's close sits at 0% of that range, 90.6% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — NNNN slides 11.8% to $5.55
- Closed at $5.55, -11.76% vs the prior close of $6.29. Day range $5.54–$6.17, opened at $6.17.
- Volume was 27.20K shares, 0.2x its 50-day average of 176.27K — lighter than usual.
- Price is -28.7% vs its 50-day average ($7.79) and -72.6% vs its 200-day average ($20.26).
- 52-week range $5.13–$51.33; today's close sits at 1% of that range, 89.2% below the 52-week high.
NNNN latest news & SEC filings
Every SEC filing by or about NNNN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Things to know before you trade NNNN
- How much it moves: over the last 20 sessions the average daily move was 5.05% (largest 16.2%). That is a volatile stock.
- Liquidity: about 109.67K shares (≈$361.89K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.30 vs a range of $3.09–$44.73 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K May 19, 2026; 6-K Apr 27, 2026; 20-F Apr 7, 2026.
- Listing: Nasdaq · industry: In Vitro & In Vivo Diagnostic Substances.
NNNN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 3.53 | 3.70 | 3.09 | 3.30 | 69.70K |
| Oct 14, 2026 | 4.26 | 4.26 | 3.52 | 3.57 | 30.60K |
| Oct 13, 2026 | 4.40 | 4.43 | 3.88 | 4.26 | 46.00K |
| Oct 12, 2026 | 4.61 | 4.68 | 4.41 | 4.41 | 24.90K |
| Oct 9, 2026 | 4.63 | 5.16 | 4.16 | 4.66 | 69.80K |
| Oct 8, 2026 | 4.81 | 4.81 | 4.55 | 4.62 | 34.70K |
| Oct 7, 2026 | 4.76 | 4.99 | 4.72 | 4.90 | 36.70K |
| Oct 6, 2026 | 4.89 | 5.15 | 4.69 | 4.90 | 52.80K |
| Oct 5, 2026 | 5.60 | 5.60 | 4.66 | 4.83 | 107.40K |
| Oct 2, 2026 | 6.17 | 6.17 | 5.54 | 5.55 | 27.20K |
| Oct 1, 2026 | 6.34 | 6.43 | 6.16 | 6.29 | 12.60K |
| Sep 30, 2026 | 6.07 | 6.33 | 5.90 | 6.30 | 26.80K |
| Sep 29, 2026 | 6.08 | 6.24 | 6.01 | 6.16 | 42.90K |
| Sep 28, 2026 | 6.25 | 6.60 | 6.01 | 6.09 | 29.70K |
| Sep 25, 2026 | 6.15 | 6.36 | 5.95 | 6.30 | 60.20K |
| Sep 24, 2026 | 6.09 | 6.76 | 6.03 | 6.15 | 114.60K |
| Sep 23, 2026 | 5.56 | 6.95 | 5.51 | 6.06 | 635.60K |
| Sep 22, 2026 | 5.69 | 5.72 | 5.46 | 5.58 | 230.20K |
| Sep 21, 2026 | 5.30 | 5.80 | 5.30 | 5.68 | 250.90K |
| Sep 18, 2026 | 5.64 | 5.66 | 5.13 | 5.25 | 290.00K |
About Anbio Biotechnology
Anbio Biotechnology (NNNN) is listed on the Nasdaq and classified by the SEC under “In Vitro & In Vivo Diagnostic Substances”. Its business address is in FRANKFURT AM MAIN, Germany. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 1982708.
NNNN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David H Hsu | Director | Jun 12, 2026 |
| Nancy Hartzler | Director | Apr 8, 2026 |
| Cany Xu | Director | Apr 8, 2026 |
| Michael W.C Zhang | Director | Jun 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael Lau | CEO | Apr 8, 2026 |
| Suki Song | CFO | Apr 8, 2026 |
| Chris Tian | CBO | Apr 8, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
NNNN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
NNNN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · In Vitro & In Vivo Diagnostic Substances
Idexx Laboratories (IDXX)Lantheus (LNTH)Intellia Therapeutics (NTLA)Neogen (NEOG)Celldex Therapeutics (CLDX)QuidelOrtho (QDEL)Achieve Life Sciences (ACHV)Myriad Genetics (MYGN)Alpha Teknova (TKNO)Insight Molecular Diagnostics (IMDX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on NNNN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.